VOYAGER THERAPEUTICS INC (VYGR) Stock Analyst Earnings Estimates
NASDAQ:VYGR - Nasdaq - US92915B1061 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 37.4M -78.14% | 40.9M 9.36% | 250.008M 511.27% | 92.1M -63.16% | 69.604M -24.43% | 85.936M 23.46% | 79.751M -7.20% | 112.59M 41.18% | 81.515M -27.60% | 111.87M 37.24% | 233.93M 109.11% | 460.25M 96.75% | |
| EBITDA YoY % growth | -68.43M -319.19% | -44.61M 34.81% | 126.455M 383.47% | -63.984M -150.60% | -112.492M -75.81% | -105.566M 6.16% | -120.36M -14.01% | -148.155M -23.09% | -139.383M 5.92% | -89.25M 35.97% | 219.61M 346.06% | 712.16M 224.28% | |
| EBIT YoY % growth | -73.6M -368.61% | -50.8M 30.98% | 122.014M 340.19% | -70.951M -158.15% | -111.155M -56.67% | -105.523M 5.07% | -131.107M -24.24% | -100.515M 23.33% | -162.733M -61.90% | -161.616M 0.69% | -4.5M 97.22% | 276.7M 6,248.56% | |
| Operating Margin | -196.79% | -124.21% | 48.80% | -77.04% | -159.70% | -122.79% | -164.40% | -89.27% | -199.64% | -144.47% | -1.92% | 60.12% | |
| EPS YoY % growth | -1.90 -300.00% | -1.22 35.79% | 3.09 353.28% | -0.94 -130.32% | -1.57 -67.68% | -1.25 20.33% | -1.21 3.57% | -0.39 67.46% | -1.08 -175.32% | -0.50 54.01% | 0.19 138.46% | 1.70 786.67% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.39 -131.15% | -0.55 -176.25% | -0.45 -149.33% | -0.46 -186.88% | -0.58 -49.75% |
| Revenue Q2Q % growth | 15.823M -82.43% | 8.005M -58.98% | 15.541M -47.46% | 15.847M -35.66% | 8.005M -49.41% |
| EBITDA Q2Q % growth | -23.613M -140.36% | -37.74M -151.82% | -38.76M -302.20% | -40.8M -305.57% | -40.8M -72.79% |
| EBIT Q2Q % growth | -27.397M -150.68% | -43.357M -167.92% | -33.1M -170.76% | -34.749M -152.17% | -50.005M -82.52% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.16 72.88% | -0.46 | 0.30 | 65.43% |
| Q2 2024 Q2Q % growth | -0.18 64.71% | -0.42 | 0.24 | 56.91% |
| Q1 2024 Q2Q % growth | -0.20 -106.80% | -0.45 | 0.25 | 55.44% |
| Q4 2023 Q2Q % growth | 1.25 304.92% | -0.29 | 1.54 | 524.68% |
| Q3 2023 Q2Q % growth | -0.59 -231.11% | -0.59 | 0.00 | 0.49% |
| Q2 2023 Q2Q % growth | -0.51 -2.00% | -0.58 | 0.07 | 12.06% |
| Q1 2023 Q2Q % growth | 2.94 625.00% | 0.79 | 2.15 | 273.52% |
| Q4 2022 Q2Q % growth | -0.61 -506.67% | -0.56 | -0.05 | -9.30% |
| Q3 2022 Q2Q % growth | 0.45 167.16% | -0.32 | 0.77 | 239.11% |
| Q2 2022 Q2Q % growth | -0.50 37.50% | -0.32 | -0.18 | -54.39% |
| Q1 2022 Q2Q % growth | -0.56 3.45% | -0.35 | -0.21 | -59.46% |
| Q4 2021 Q2Q % growth | 0.15 134.88% | -0.32 | 0.47 | 146.44% |
| Q3 2021 Q2Q % growth | -0.67 -129.52% | -0.74 | 0.07 | 9.71% |
| Q2 2021 Q2Q % growth | -0.80 -247.83% | -0.73 | -0.07 | -10.08% |
| Q1 2021 Q2Q % growth | -0.58 12.12% | -0.67 | 0.09 | 13.32% |
| Q4 2020 Q2Q % growth | -0.43 -26.47% | -0.58 | 0.15 | 25.40% |
| Q3 2020 Q2Q % growth | 2.27 653.66% | -0.20 | 2.47 | 1,263.66% |
| Q2 2020 Q2Q % growth | -0.23 -179.31% | -0.73 | 0.50 | 68.54% |
| Q1 2020 Q2Q % growth | -0.66 18.52% | -0.81 | 0.15 | 18.21% |
| Q4 2019 Q2Q % growth | -0.34 | -0.82 | 0.48 | 58.71% |
| Q3 2019 Q2Q % growth | -0.41 | -0.77 | 0.36 | 46.88% |
| Q2 2019 Q2Q % growth | 0.29 | -0.77 | 1.06 | 137.78% |
| Q1 2019 Q2Q % growth | -0.81 | 0.59 | -1.40 | -236.19% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 24.629M 433.79% | 12.129M | 12.5M | 103.06% |
| Q2 2024 Q2Q % growth | 29.578M 509.48% | 9.65M | 19.928M | 206.51% |
| Q1 2024 Q2Q % growth | 19.516M -87.03% | 9.603M | 9.913M | 103.23% |
| Q4 2023 Q2Q % growth | 90.061M 6,104.07% | 21.048M | 69.013M | 327.88% |
| Q3 2023 Q2Q % growth | 4.614M -88.77% | 2.966M | 1.648M | 55.56% |
| Q2 2023 Q2Q % growth | 4.853M 593.29% | 1.632M | 3.221M | 197.37% |
| Q1 2023 Q2Q % growth | 150.48M 21,397.14% | 41.82M | 108.66M | 259.83% |
| Q4 2022 Q2Q % growth | -1.5M -105.34% | 4.271M | -5.771M | -135.12% |
| Q3 2022 Q2Q % growth | 41.1M 2,640.00% | 9.604M | 31.496M | 327.95% |
| Q2 2022 Q2Q % growth | 700K -50.00% | 13.041M | -12.341M | -94.63% |
| Q1 2022 Q2Q % growth | 700K -89.23% | 14.705M | -14.005M | -95.24% |
| Q4 2021 Q2Q % growth | 28.1M 332.31% | 14.837M | 13.263M | 89.39% |
| Q3 2021 Q2Q % growth | 1.5M -98.73% | 2.186M | -686K | -31.38% |
| Q2 2021 Q2Q % growth | 1.4M -95.12% | 4.867M | -3.467M | -71.23% |
| Q1 2021 Q2Q % growth | 6.5M -64.09% | 5.523M | 977K | 17.69% |
| Q4 2020 Q2Q % growth | 6.5M -80.12% | 13.584M | -7.084M | -52.15% |
| Q3 2020 Q2Q % growth | 117.8M 477.45% | 38.082M | 79.718M | 209.33% |
| Q2 2020 Q2Q % growth | 28.7M -37.74% | 15.836M | 12.864M | 81.23% |
| Q1 2020 Q2Q % growth | 18.1M 248.08% | 13.817M | 4.283M | 31.00% |
| Q4 2019 Q2Q % growth | 32.7M | 11.144M | 21.556M | 193.43% |
| Q3 2019 Q2Q % growth | 20.4M | 7.792M | 12.608M | 161.81% |
| Q2 2019 Q2Q % growth | 46.1M | 7.789M | 38.311M | 491.86% |
| Q1 2019 Q2Q % growth | 5.2M | 49.248M | -44.048M | -89.44% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 14.5% | 0% | 34.42% |
| Revenue | 0% | 54.33% | -0.66% | 30.55% |